We are monitoring the impact of COVID-19 & Recession alarm on Latin America Uterine Cancer Therapeutics Market Get in touch with us for detailed analysis Know More
Share on

Latin America Uterine Cancer Therapeutics Market Research Report – Segmented By Type, Therapy, Country (Mexico, Brazil, Argentina, Chile & Rest of Latin America) - Industry Analysis, Size, Share, Growth, Trends, Forecast (2022 to 2027)

Published: January, 2022
ID: 1414
Pages: 137

Latin America Uterine Cancer Therapeutics Market Size (2022 to 2027)

The size of the Uterine Cancer Therapeutics Market in Latin America is expected to worth USD 2.31 billion by 2027 and USD 1.74 billion in 2022, growing at a CAGR of 5.89% during the forecast period.

Uterine cancer is a type of cancer of the female reproductive system that starts in the uterus lining. According to the American Cancer Society, about 47,130 new instances of endometrial cancer were identified in 2012, with 8,010 people suffering from it. According to the American Association for Cancer Research, endometrial carcinoma is a common disease worldwide, but uterine sarcoma is rare cancer. Endometrial carcinomas account for around 68 percent of uterine cancers, according to the CDC. 

The Latin American Uterine Cancer Therapeutics Market is expected to witness a significant CAGR due to increasing awareness among the people in the region regarding the uterine cancer and rising healthcare expenditure. Also, growing advancements in cancer screening & treatment methods and a rising number of newly diagnosed uterine cancer cases drive the growth of the Latin American Uterine Cancer Therapeutics market. 

In addition, the government rising focus on providing suitable healthcare solutions and increasing developments in the molecular diagnostics industry to enable target-specific medicines are projected to drive market growth. As a result, both physicians and health care professionals are becoming more aware of the frequency of uterine cancer and are learning more about the therapies available to treat these diseases, which is expected to impact the market growth positively. Further, increasing in urban healthcare spending and government initiatives to enhance healthcare infrastructure, advancements in medical innovation, and new uterine cancer medicines encourage people to invest in proper treatment.

Furthermore, the further expansion of the Latin America market is being fuelled by rapid diagnostic technology advancements and faster acceptance of new technologies in the countries such as Mexico and Brazil. growing advances in cancer screening & treatment methods, besides raising awareness among patients, further stimulates the global Uterine Cancer Therapeutics market.

However, the low success rate of cancer drug clinical trials, expensive treatment techniques, adverse side effects, and high toxicity of these drugs are all expected to hinder Latin American market growth in uterine cancer therapeutics.

This research report on the Latin American Uterine Cancer Therapeutics Market is segmented & sub-segmented into the following categories:

By Type:

  • Uterine Sarcoma
  • Endometrial Carcinoma
  • Adenocarcinoma
  • Carcinosarcoma
  • Squamous Cell Carcinoma
  • Others

By Therapy:

  • Surgery
  • Chemotherapy
  • Radiation Therapy
  • Immunotherapy
  • Hormone Therapy

By Country:

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

The Latin America Uterine Cancer Therapeutics Market is estimated to grow at a promising rate during the forecast period. The market growth in this region is primarily driven by Increasing cases of women being diagnosed with uterine cancer throughout the region and growing in the importance of targeted drug therapies. Also, an increase in risk factors leading to cancer and increasing investment from government, public & private organizations for developing novel drugs to treat cancer also acts as a market driver in the Latin American Uterine Cancer Therapeutics. The Latin American market growth is driven due to the government and the healthcare providers; it has been indicated that the market will grow rapidly over the forecast period. In addition, developing countries such as Mexico and Brazil contribute to the development of regional cancer centers. Moreover, the initiatives taken by the government for creating cancer awareness programs are positively impacting the market growth in the region.

KEY MARKET PLAYERS:

A few of the promising companies in the Latin American Uterine Cancer Therapeutics market profiled in this report are Abbott Laboratories, Ariad Pharmaceuticals, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Merck & Co., Inc., Novartis AG, Sanofi, Siemens Healthcare GmbH and Takeda Pharmaceutical Company Ltd.

1.Introduction                

                1.1 Market Definition  

                1.2 Study Deliverables

                1.3 Base Currency, Base Year and Forecast Periods         

                1.4 General Study Assumptions                

2. Research Methodology       

                2.1 Introduction            

                2.2 Research Phases    

              2.2.1 Secondary Research            

              2.2.2 Primary Research 

              2.2.3 Econometric Modelling     

              2.2.4 Expert Validation  

                2.3 Analysis Design       

                2.4 Study Timeline        

3. Overview  

                3.1 Executive Summary                

                3.2 Key Inferences       

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)  

                4.1 Market Drivers        

                4.2 Market Restraints  

                4.3 Key Challenges       

                4.4 Current Opportunities in the Market               

5. Market Segmentation          

                5.1 By Type      

              5.1.1 Endometrial Carcinoma     

            5.1.2.1 Adenocarcinoma

            5.1.2.2 Carcinosarcoma

            5.1.2.3 Squamous cell carcinoma

            5.1.2.4 Others

              5.1.2 Uterine Sarcoma  

                5.2 By Therapy                 

              5.2.1 Surgery    

              5.2.2 Chemotherapy     

              5.2.3 Radiation Therapy

              5.2.4 Immunotherapy   

              5.2.5 Hormone Therapy

6. Geographical Analysis          

                6.1 Introduction            

                6.2 Brazil           

                6.3 Mexico       

                6.4 Rest of Latin America           

7. Pipeline Product Analysis    

                7.1 Overview  

                7.2 Pipeline Development Landscape   

                7.3 Molecular Targets in the Pipeline    

                7.4 Clinical Trials            

              7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target       

              7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target                

              7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target               

8.Strategic Analysis    

                8.1 PESTLE analysis       

              8.1.1 Political     

              8.1.2 Economic 

              8.1.3 Social         

              8.1.4 Technological         

              8.1.5 Legal          

              8.1.6 Environmental      

                8.2 Porter’s Five analysis            

              8.2.1 Bargaining Power of Suppliers        

              8.2.2 Bargaining Power of Consumers    

              8.2.3 Threat of New Entrants     

              8.2.4 Threat of Substitute Products and Services

              8.2.5 Competitive Rivalry within the Industry      

              8.2.4 Threat of Substitute Products and Services

              8.2.5 Competitive Rivalry within the Industry      

9.Market Leaders' Analysis      

                9.1 Abbott Laboratories (U.S.) 

              9.1.1 Overview

              9.1.2 Product Analysis   

              9.1.3 Financial analysis  

              9.1.4 Recent Developments       

              9.1.5 SWOT analysis       

              9.1.6 Analyst View          

                9.2 Ariad Pharmaceuticals, Inc. (U.S.)   

                9.3 Becton, Dickinson and Company (U.S.)         

                9.4 F. Hoffmann-La Roche AG (Switzerland)      

                9.5 GlaxoSmithKline Plc (U.K.) 

                9.6 Merck & Co., Inc. (U.S.)       

                9.7 Novartis AG (Switzerland)  

                9.8 Sanofi (France)       

                9.9 Siemens Healthcare GmbH (Germany)         

                9.10 Takeda Pharmaceutical Company Ltd. (Japan)        

10.Competitive Landscape      

                10.1 Market share analysis        

                10.2 Merger and Acquisition Analysis   

                10.3 Agreements, collaborations and Joint Ventures     

                10.4 New Product Launches     

11.Market Outlook & Investment Opportunities             

Appendix       

                a) List of Tables                

                b) List of Figures            

 

  1. Latin America Uterine Cancer Therapeutics Market, By Region, From 2022 - 2027 (USD Billion)
  2. Latin America Uterine Cancer Therapeutics Market, By Type, From 2022 - 2027 (USD Billion)
  3. Latin America Endometrial Carcinoma Market, By Region, From 2022 - 2027 (USD Billion)
  4. Latin America Uterine Sarcoma Market, By Region, From 2022 - 2027 (USD Billion)
  5. Latin America Uterine Cancer Therapeutics Market, By Therapy, From 2022 - 2027 (USD Billion)
  6. Latin America Uterine Cancer Surgery Market, By Region, From 2022 - 2027 (USD Billion)
  7. Latin America Uterine Cancer Chemotherapy Market, By Region, From 2022 - 2027 (USD Billion)
  8. Latin America Uterine Cancer Immunotherapy Market, By Region, From 2022 - 2027 (USD Billion)
  9. Latin America Uterine Cancer Radiation Therapy Market, By Region, From 2022 - 2027 (USD Billion)
  10. Latin America Uterine Cancer Hormone Therapy Market, By Region, From 2022 - 2027 (USD Billion)
  11. Brazil Uterine Cancer Therapeutics Market, By Type, From 2022 - 2027 (USD Billion)
  12. Brazil Uterine Cancer Therapeutics Market, By Therapy, From 2022 - 2027 (USD Billion)
  13. Argentina Uterine Cancer Therapeutics Market, By Type, From 2022 - 2027 (USD Billion)
  14. Argentina Uterine Cancer Therapeutics Market, By Therapy, From 2022 - 2027 (USD Billion)
  15. Mexico Uterine Cancer Therapeutics Market, By Type, From 2022 - 2027 (USD Billion)
  16. Mexico Uterine Cancer Therapeutics Market, By Therapy, From 2022 - 2027 (USD Billion)
  17. Latin America Endometrial Carcinoma Market, By Type, From 2022 - 2027 (USD Billion)
  18. Latin America Adenocarcinoma Market, By Region, From 2022 - 2027 (USD Billion)
  19. Latin America Carcinosarcoma Market, By Region, From 2022 - 2027 (USD Billion)
  20. Latin America Squamous cell carcinoma Market, By Region, From 2022 - 2027 (USD Billion)
  21. Latin America Other Endometrial Carcinoma Market, By Region, From 2022 - 2027 (USD Billion)
  22. Brazil Endometrial Carcinoma Market, By Type, From 2022 - 2027 (USD Billion)
  23. Argentina Endometrial Carcinoma Market, By Type, From 2022 - 2027 (USD Billion)
  24. Mexico Endometrial Carcinoma Market, By Type, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample